China's first lawsuit filed by companies against national market regulator over $47 million fine
The judges of China’s Beijing High People’s Court on November 22 heard the arguments in a dispute between two Chinese pharmaceutical companies and the State Administration for Market Regulation (SAMR), China’s highest market regulator.